US2022184169A1PendingUtilityA1
Compositions of herbal formulations and uses thereof
Est. expiryMay 16, 2031(~4.8 yrs left)· nominal 20-yr term from priority
A61K 36/577A61K 36/185A61K 36/808A61K 36/71A61K 36/77A61P 13/08A61K 36/66A61P 13/12A61K 36/899A61K 36/27A61K 36/35A61K 36/31A61K 36/90A61P 11/00A61K 36/23A61P 29/00A61K 36/29A61K 36/24A61K 36/76A61K 36/48A61P 37/00A61K 36/22A61P 11/06A61P 19/02A61K 36/68A61P 43/00A61P 9/14A61P 15/00A61P 17/00A61P 13/10A61P 37/08A61K 36/28A61P 1/00
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A composition comprising:
a mixture of at least four different plant extracts, wherein each of the at least four plant extracts is selected from the group consisting of Achillea millefolium; Aesuculus hippocastanum; Althaea officinalis; Avena sativa; Berberis vulgaris; Capsella bursa - pastoris; Cochlearia officinalis; Conium maculatium; Ervum lens; Hamamelis virginiana; Hydrastis canadensis; Malva sylvestris; Matricaria chamomilla; Nasturtium officinale; Phytolacca decendra; Pimpinella saxifraga; Populus alba; Populus tremuloides; Rhus toxicodendron; Sambucus nigra; Sanguinaria canadensis; Scrophularia nodosa; Smilax medica; Tussilago farfara; Veronica officinalis; Vincetoxicum officinale ; and combinations thereof; and at least one pharmaceutically acceptable carrier, diluent, or excipient.
2 . The composition of claim 1 , wherein the mixture comprises at least five different plant extracts.
3 . The composition of claim 1 , wherein the mixture comprises at least six different plant extracts.
4 . The composition of claim 1 , wherein the mixture comprises at least seven different plant extracts.
5 . The composition of claim 1 , wherein the mixture comprises at least eight different plant extracts.
6 . The composition of claim 1 , wherein the mixture comprises at least nine different plant extracts.
7 . The composition of claim 1 , wherein the mixture comprises at least ten different plant extracts.
8 . The composition of claim 1 , wherein the mixture comprises at least eleven different plant extracts.
9 . The composition of claim 1 , wherein the mixture comprises at least twelve different plant extracts.
10 . The composition of claim 1 , wherein the mixture comprises at least thirteen different plant extracts.
11 . The composition of claim 1 , wherein the mixture comprises at least fourteen different plant extracts.
12 . The composition of claim 1 , wherein the mixture comprises at least fifteen different plant extracts.
13 . The composition of claim 1 , wherein the mixture comprises at least sixteen different plant extracts.
14 . The composition of claim 1 , wherein the mixture comprises at least seventeen different plant extracts.
15 . The composition of claim 1 , wherein the mixture comprises at least eighteen different plant extracts.
16 . The composition of claim 1 , wherein the mixture comprises plant extracts obtained from Achillea millefolium; Aesuculus hippocastanum; Althaea officinalis; Avena sativa; Berberis vulgaris; Capsella Bursa Pastoris; Cochlearia officinalis; Ervum lens; Hamamelis virginiana; Matricaria chamomilla; Nasturtium officinale; Phytolacca decandra; Pimpinella saxifraga; Populas alba; Populus tremuloides; Sambucus nigra; Sanguinaria Canadensis; Scrophularia nodosa; Smilax medica; Tussilago farfara; Veronica officinalis ; and Vincetoxicum officinale.
17 . The composition of claim 1 , wherein the composition is in the form of an oral composition.
18 . The composition of claim 1 , wherein the composition is in the form of a topical composition, and wherein the topical composition is formulated as a cream, gel, lotion, ointment, or salve.
19 . A method of reducing symptoms associated with a skin condition in a subject, wherein the skin condition is associated with acne vulgaris, psoriasis, eczema, atopic dermatitis, pruritis, erythema, or excoriations, the method comprising the steps of:
identifying the subject in need thereof; and administering to the subject an effective amount of the composition of claim 1 .
20 . The method of claim 19 , wherein the composition is topically administered to the subject.Join the waitlist — get patent alerts
Track US2022184169A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.